Gritstone bio, Inc.
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid t…
Biotechnology
US, EmeryVille [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Gritstone bio, Inc. has no acquisition track records yet.
M&A Deals · History
Gritstone bio, Inc. has no acquisition track records yet.